This list is an analysis based on recent market events. It's not an investment recommendation.
Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. It develops Sevuparin, a lipopolysaccharide in Phase IIa trial to treat patients with sepsis, septic shock, anemia associated with chronic kidney disease, endotoxemia, severe malaria, and other diseases involving severe systemic inflammation. Modus Therapeutics Holding AB (publ) was founded in 2011 and is headquartered in Stockholm, Sweden.
FAQs
What is Modus Therapeutics AB stock price today?▼
The current price of MODTX.ST is SEK0.18 SEK — it has increased by +1.1% in the past 24 hours. Watch Modus Therapeutics AB stock price performance more closely on the chart.
What is Modus Therapeutics AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange Modus Therapeutics AB stocks are traded under the ticker MODTX.ST.
Is Modus Therapeutics AB stock price growing?▼
MODTX.ST stock has fallen by -4.91% compared to the previous week, the month change is a -53.3% fall, over the last year Modus Therapeutics AB has showed a -55.34% decrease.
What is Modus Therapeutics AB market cap?▼
Today Modus Therapeutics AB has the market capitalization of 27.36M
What is Modus Therapeutics AB revenue for the last year?▼
Modus Therapeutics AB revenue for the last year amounts to 0 SEK.
What is Modus Therapeutics AB net income for the last year?▼
MODTX.ST net income for the last year is -4.65M SEK.
How many employees does Modus Therapeutics AB have?▼
As of November 2, 2026, the company has 2 employees.
In which sector is Modus Therapeutics AB located?▼
Modus Therapeutics AB operates in the Health & Wellness sector.
When did Modus Therapeutics AB complete a stock split?▼
Modus Therapeutics AB has not had any recent stock splits.
Where is Modus Therapeutics AB headquartered?▼
Modus Therapeutics AB is headquartered in Stockholm, Sweden.